Accedi

Bibliografie tematiche / Neuroendocrine transdifferentiation

Indice

Articoli di riviste
Tesi
Atti di convegni

Letteratura scientifica selezionata sul tema "Neuroendocrine transdifferentiation"

Autore: Grafiati

Pubblicato: 21 settembre 2024

Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili

Scegli il tipo di fonte:

Consulta la lista di attuali articoli, libri, tesi, atti di convegni e altre fonti scientifiche attinenti al tema "Neuroendocrine transdifferentiation".

Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.

Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.

Articoli di riviste sul tema "Neuroendocrine transdifferentiation"

1

Sergeant, Camille, Christel Jublanc, Delphine Leclercq, et al. "Transdifferentiation of Neuroendocrine Cells." American Journal of Surgical Pathology 41, no. 6 (2017): 849–53. http://dx.doi.org/10.1097/pas.0000000000000803.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

2

Stone, Louise. "A novel mechanism of neuroendocrine transdifferentiation." Nature Reviews Urology 15, no. 5 (2018): 263. http://dx.doi.org/10.1038/nrurol.2018.40.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

3

Cordeiro-Rudnisky, Fernanda, Yue Sun, and Rayan Saade. "Prostate Carcinoma With Overlapping Features of Small Cell and Acinar Adenocarcinoma: A Case Report." American Journal of Clinical Pathology 152, Supplement_1 (2019): S66—S67. http://dx.doi.org/10.1093/ajcp/aqz113.072.

Testo completo

Abstract (sommario):

Abstract Introduction Prostate neuroendocrine (NE) cells can stimulate prostate adenocarcinoma (PA) cell growth, but occasionally adenocarcinoma cells themselves acquire NE characteristics, a phenomenon known as NE transdifferentiation of prostate adenocarcinoma. During this process, tumor cells acquire small cell-like morphology and become positive for neuroendocrine markers. NE transdifferentiation is associated with decreased androgen receptor (AR) signaling, a mechanism of resistance to AR-targeted treatments. Case A 74-year-old male with a history of cirrhosis, splenomegaly, and thrombocy

Gli stili APA, Harvard, Vancouver, ISO e altri

4

Quintanal-Villalonga, Alvaro, Hirokazu Taniguchi, Yingqian A. Zhan, et al. "AKT inhibition as a therapeutic strategy to constrain histological transdifferentiation in EGFR-mutant lung adenocarcinoma." Journal of Clinical Oncology 40, no. 16_suppl (2022): e21166-e21166. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e21166.

Testo completo

Abstract (sommario):

e21166 Background: In lung adenocarcinomas (LUADs), lineage plasticity drives neuroendocrine (NE) and squamous cell (LUSC) transdifferentiation in the context of acquired resistance to targeted inhibition of driver mutations, with up to 14% and 9% incidences in EGFR-mutant tumors relapsed on EGFR inhibitors, respectively. Notably, survival of patients with NE- or LUSC-transdifferentiated tumors is remarkably lower than those of LUAD or de novo LUSC patients. The paucity of transforming clinical specimens amenable for molecular analyses has hindered the identification of histological transforma

Gli stili APA, Harvard, Vancouver, ISO e altri

5

Yuan, Ta-Chun, Suresh Veeramani, and Ming-Fong Lin. "Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells." Endocrine-Related Cancer 14, no. 3 (2007): 531–47. http://dx.doi.org/10.1677/erc-07-0061.

Testo completo

Abstract (sommario):

Neuroendocrine (NE) cells represent a minor cell population in the epithelial compartment of normal prostate glands and may play a role in regulating the growth and differentiation of normal prostate epithelia. In prostate tumor lesions, the population of NE-like cells, i.e., cells exhibiting NE phenotypes and expressing NE markers, is increased that correlates with tumor progression, poor prognosis, and the androgen-independent state. However, the origin of those NE-like cells in prostate cancer (PCa) lesions and the underlying molecular mechanism of enrichment remain an enigma. In this revie

Gli stili APA, Harvard, Vancouver, ISO e altri

6

Von Amsberg, Gunhild, Sergey Dyshlovoy, Jessica Hauschild, et al. "Long-term taxane exposure and transdifferentiation of prostate cancer in vitro." Journal of Clinical Oncology 41, no. 6_suppl (2023): 254. http://dx.doi.org/10.1200/jco.2023.41.6_suppl.254.

Testo completo

Abstract (sommario):

254 Background: Development of aggressive variants of metastatic castration-resistant prostate cancer (AVPC) is a major challenge in the course of therapy but the underlying mechanisms of aggressive transdifferentiation are not completely understood and appropriate tumor models are missing. Here, we investigated the consequences of long-term taxane exposure on hormone-independent, BRCA2-mutated, AR-V7-positive 22Rv1 cells. Methods: 22Rv1 cells were treated with stepwise increased taxane concentrations for 10 months. Individual clones were picked and further cultured in media containing either

Gli stili APA, Harvard, Vancouver, ISO e altri

7

Quintanal-Villalonga, Alvaro, Hirokazu Taniguchi, Yingqian A. Zhan, et al. "Abstract 658: AKT pathway as a therapeutic target to constrain lineage plasticity leading to histological transdifferentiation." Cancer Research 82, no. 12_Supplement (2022): 658. http://dx.doi.org/10.1158/1538-7445.am2022-658.

Testo completo

Abstract (sommario):

Abstract Lineage plasticity contributes to therapeutic resistance in cancer. In lung adenocarcinomas (LUADs), this phenomenon drives neuroendocrine (NE) and squamous cell (LUSC) histologic transdifferentiation in the context of acquired resistance to targeted inhibition of driver mutations, with up to 14% and 9% incidences in EGFR-mutant tumors relapsed on EGFR inhibitors, respectively. Notably, survival of patients with NE- or LUSC-transdifferentiated tumors is lower than that of either LUAD or de novo LUSC patients. To date, little is known about the molecular effectors enhancing lineage pla

Gli stili APA, Harvard, Vancouver, ISO e altri

8

Frigo, Daniel E., and Donald P. McDonnell. "Differential effects of prostate cancer therapeutics on neuroendocrine transdifferentiation." Molecular Cancer Therapeutics 7, no. 3 (2008): 659–69. http://dx.doi.org/10.1158/1535-7163.mct-07-0480.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

9

Patel, Girijesh, Sayanika Dutta, Mosharaf Mahmud Syed, et al. "TBX2 Drives Neuroendocrine Prostate Cancer through Exosome-Mediated Repression of miR-200c-3p." Cancers 13, no. 19 (2021): 5020. http://dx.doi.org/10.3390/cancers13195020.

Testo completo

Abstract (sommario):

Deciphering the mechanisms that drive transdifferentiation to neuroendocrine prostate cancer (NEPC) is crucial to identifying novel therapeutic strategies against this lethal and aggressive subtype of advanced prostate cancer (PCa). Further, the role played by exosomal microRNAs (miRs) in mediating signaling mechanisms that propagate the NEPC phenotype remains largely elusive. The unbiased differential miR expression profiling of human PCa cells genetically modulated for TBX2 expression led to the identification of miR-200c-3p. Our findings have unraveled the TBX2/miR-200c-3p/SOX2/N-MYC signal

Gli stili APA, Harvard, Vancouver, ISO e altri

10

Turner, Leo, Andrew Burbanks, and Marianna Cerasuolo. "Mathematical insights into neuroendocrine transdifferentiation of human prostate cancer cells." Nonlinear Analysis: Modelling and Control 26, no. 5 (2021): 884–913. http://dx.doi.org/10.15388/namc.2021.26.24441.

Testo completo

Abstract (sommario):

Prostate cancer represents the second most common cancer diagnosed in men and the fifth most common cause of death from cancer worldwide. In this paper, we consider a nonlinear mathematical model exploring the role of neuroendocrine transdifferentiation in human prostate cancer cell dynamics. Sufficient conditions are given for both the biological relevance of the model’s solutions and for the existence of its equilibria. By means of a suitable Liapunov functional the global asymptotic stability of the tumour-free equilibrium is proven, and through the use of sensitivity and bifurcation analys

Gli stili APA, Harvard, Vancouver, ISO e altri

Tesi sul tema "Neuroendocrine transdifferentiation"

1

Guo, Yingbo. "Rôle du cil primaire au cours de la transdifferentiation neuroendocrine du cancer de la prostate." Electronic Thesis or Diss., Université Côte d'Azur, 2024. http://www.theses.fr/2024COAZ6005.

Testo completo

Abstract (sommario):

Le cancer de la prostate est l’un des cancers malins les plus répandus dans le monde, avec 95 % des patients diagnostiqués présentant un adénocarcinome de la prostate sans marqueurs neuroendocriniens. Le cancer neuroendocrinien de la prostate de novo représente un sous-type rare et agressif. Environ 20 % des cas d’adénocarcinome de la prostate évoluent vers le cancer neuroendocrinien de la prostate après un traitement de privation androgénique. Le traitement de privation androgénique bien qu’efficace, peut également induire une différenciation neuroendocrinienne de l'adénocarcinome de la prost

Gli stili APA, Harvard, Vancouver, ISO e altri

Atti di convegni sul tema "Neuroendocrine transdifferentiation"

1

Li, Yinan. "Abstract 4473: SRRM4 drives treatment-induced neuroendocrine transdifferentiation of prostate adenocarcinoma under androgen receptor pathway inhibition." In Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-4473.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

2

Beshiri, Mike L., Caitlin M. Tice, Adam G. Sowalsky, et al. "Abstract 5020: A patient-derived organoid model of neuroendocrine prostate cancer transdifferentiation informing the role of the BAF complex component ARID1A." In Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.am2018-5020.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

Offriamo sconti su tutti i piani premium per gli autori le cui opere sono incluse in raccolte letterarie tematiche. Contattaci per ottenere un codice promozionale unico!